In a regulatory filing, ADMA Biologics disclosed that its director Bryant Fong sold 1.43M shares of common stock on August 22nd in a total transaction size of $5.54M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ADMA:
- ADMA Biologics price target raised to $6 from $5 at Raymond James
- ADMA Biologics price target raised to $7 from $6 at Mizuho
- ADMA Biologics price target raised to $5 from $4.50 at H.C. Wainwright
- ADMA Earnings this Week: How Will it Perform?
- ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023